PharmaShots | Incisive News in 3 Shots

Subscribe Now

biotech

AstraZeneca's Lokelma Receives Fast Track Designation for the Treatment of Chronic Haemodialysis with Hyperkalaemia

AstraZeneca's Lokelma Receives Fast Track Designation for the Treatment of Chronic Haemodialysis with Hyperkalaemia

November 18, 2021

AstraZeneca Reports Results of AZD7442 in P-III PROVENT and TACKLE Trial for the Treatment of COVID-19

AstraZeneca Reports Results of AZD7442 in P-III PROVENT and TACKLE Trial for the Treatment of COVID-19

November 18, 2021

AstraZeneca's Lokelma Receives Fast Track Designation for the Treatment of Chronic Haemodialysis with Hyperkalaemia

AstraZeneca's Lokelma Receives Fast Track Designation for the Treatment of Chronic Haemodialysis with Hyperkalaemia

November 18, 2021

AstraZeneca Reports Results of AZD7442 in P-III PROVENT and TACKLE Trial for the Treatment of COVID-19

AstraZeneca Reports Results of AZD7442 in P-III PROVENT and TACKLE Trial for the Treatment of COVID-19

November 18, 2021

Janssen and BMS Present Results of Milvexian in P-II AXIOMATIC-TKR Study for the Treatment of TKR Surgery at AHA 2021, Published in NEJM

Janssen and BMS Present Results of Milvexian in P-II AXIOMATIC-TKR Study for the Treatment of TKR Surgery at AHA 2021, Published i...

November 16, 2021

Janssen and BMS Present Results of Milvexian in P-II AXIOMATIC-TKR Study for the Treatment of TKR Surgery at AHA 2021, Published in NEJM

Janssen and BMS Present Results of Milvexian in P-II AXIOMATIC-TKR Study for the Treatment of TKR Surgery at AHA 2021, Published i...

November 16, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us